{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:45:10Z","timestamp":1787755510529,"version":"build-2784847793"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Total joint arthroplasty (TJA) is often associated with significant blood loss, leading to complications such as acute anemia and increased risk of infection and mortality. Tranexamic acid (TXA), an antifibrinolytic agent, has been recognized for effectively reducing blood loss during TJA. This systematic review and network meta-analysis aims to evaluate the efficacy and safety of oral TXA compared with other administration routes in TJA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a comprehensive literature search was conducted across multiple databases, including PubMed, Scopus, Embase, and Web of Science, focusing on randomized clinical trials involving oral TXA in TJA. The studies were assessed for quality using the Cochrane risk assessment scale. Data synthesis involved network meta-analyses, comparing outcomes including hemoglobin drop, estimated blood loss (EBL), transfusion rate, and deep vein thrombosis (DVT) rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our comprehensive literature search incorporated 39 studies with 7,538 participants, focusing on 8 TXA administration methods in TJA. The combination of oral and intra-articular (oral + IA) TXA markedly reduced hemoglobin drop more effectively than oral, intravenous (IV), and IA alone, but the difference was not significant. Oral + IA TXA significantly reduced EBL more effectively than oral + IV, IA + IV, and oral, IV, and IA alone. Perioperative transfusion rates with oral + IA TXA was significantly lower than that of oral, IA, and IV alone. The DVT rate with oral + IA was significantly lower than that with all other routes, including oral + IV, IA + IV, and oral, IA, and IV alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Oral TXA, particularly in combination with IA administration, demonstrates significantly higher efficacy in reducing blood loss and transfusion rates in TJA, with a safety profile comparable with that of other administration routes. The oral route, offering lower costs and simpler administration, emerges as a viable and preferable option in TJA procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.rvw.23.00248","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T14:09:41Z","timestamp":1718719781000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and Safety of Oral Tranexamic Acid vs. Other Routes in Total Joint Arthroplasty"],"prefix":"10.2106","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-5524","authenticated-orcid":false,"given":"Mohammad","family":"Poursalehian","sequence":"first","affiliation":[{"name":"Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4746-7620","authenticated-orcid":false,"given":"Mahboobeh","family":"Tajvidi","sequence":"additional","affiliation":[{"name":"Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4274-4628","authenticated-orcid":false,"given":"Rezvan","family":"Ghaderpanah","sequence":"additional","affiliation":[{"name":"Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-8318","authenticated-orcid":false,"given":"Mohammad","family":"Soleimani","sequence":"additional","affiliation":[{"name":"Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8253-203X","authenticated-orcid":false,"given":"Seyedeh Melika","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-1830","authenticated-orcid":false,"given":"Amir Reza","family":"Kachooei","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedics Florida at AdventHealth, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6]]},"reference":[{"issue":"2","key":"r1-20240731","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00264-018-3925-8","article-title":"The efficacy and safety of multiple-dose oral tranexamic acid on blood loss following total hip arthroplasty: a randomized controlled trial","volume":"43","author":"Cao","year":"2019","journal-title":"Int Orthop"},{"key":"r2-20240731","doi-asserted-by":"crossref","first-page":"2050312116637024","DOI":"10.1177\/2050312116637024","article-title":"Perioperative blood loss in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid use in an academic medical center","volume":"4","author":"Hogan","year":"2016","journal-title":"SAGE Open Med"},{"issue":"1","key":"r3-20240731","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arth.2015.07.040","article-title":"A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes","volume":"31","author":"Loftus","year":"2016","journal-title":"J Arthroplasty"},{"issue":"6","key":"r4-20240731","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1302\/0301-620X.91B6.22393","article-title":"The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement","volume":"91","author":"Rajesparan","year":"2009","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"r5-20240731","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review","volume":"47","author":"Ng","year":"2015","journal-title":"Anesthesiol Intensive Ther"},{"key":"r6-20240731","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijsu.2017.09.009","article-title":"Comparison of oral and intravenous tranexamic acid in total knee and hip arthroplasty: a systematic review and meta-analysis","volume":"47","author":"Hao","year":"2017","journal-title":"Int J Surg"},{"issue":"10","key":"r7-20240731","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.arth.2012.04.024","article-title":"Tranexamic acid for reduction of blood loss during total hip arthroplasty","volume":"27","author":"Imai","year":"2012","journal-title":"J Arthroplasty"},{"issue":"1","key":"r8-20240731","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2016.06.058","article-title":"Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty","volume":"32","author":"Lee","year":"2017","journal-title":"J Arthroplasty"},{"issue":"2","key":"r9-20240731","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00590-010-0671-z","article-title":"The use of tranexamic acid to reduce blood loss in primary cementless total hip arthroplasty","volume":"21","author":"Malhotra","year":"2011","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"12","key":"r10-20240731","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.arth.2014.03.032","article-title":"Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial","volume":"29","author":"Yue","year":"2014","journal-title":"J Arthroplasty"},{"issue":"3","key":"r11-20240731","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.transci.2013.09.005","article-title":"Effectiveness of oral Tranexamic acid administration on blood loss after knee arthroplasty: a randomized clinical trial","volume":"49","author":"Alipour","year":"2013","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"r12-20240731","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jse.2020.11.022","article-title":"A single dose of tranexamic acid reduces blood loss after reverse and anatomic shoulder arthroplasty: a randomized controlled trial","volume":"30","author":"Cunningham","year":"2021","journal-title":"J Shoulder Elbow Surg"},{"issue":"4","key":"r13-20240731","first-page":"344","article-title":"Tranexamic acid achieves less blood loss volume of in primary shoulder arthroplasty: a systematic review and meta-analysis of level I randomized controlled trials","volume":"1","author":"Fan","year":"2021","journal-title":"JSES Rev Rep Tech"},{"issue":"2","key":"r14-20240731","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.sart.2021.12.006","article-title":"Oral and intravenous tranexamic acid are equivalent at reducing blood loss following shoulder arthroplasty\u2014a multicenter, double-blinded, randomized, placebo-controlled trial","volume":"32","author":"Gao","year":"2022","journal-title":"Semin Arthroplasty JSES"},{"issue":"9","key":"r15-20240731","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2106\/JBJS.RVW.17.00021","article-title":"Tranexamic acid in shoulder arthroplasty: a systematic review and meta-analysis","volume":"5","author":"Kirsch","year":"2017","journal-title":"JBJS Rev"},{"issue":"11","key":"r16-20240731","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00264-018-3846-6","article-title":"Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial","volume":"42","author":"Zhao","year":"2018","journal-title":"Int Orthop"},{"issue":"6","key":"r17-20240731","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","article-title":"The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement","volume":"99","author":"Zohar","year":"2004","journal-title":"Anesth Analg"},{"issue":"3","key":"r18-20240731","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1060028017735859","article-title":"Comparison of oral and intravenous tranexamic acid for prevention of perioperative blood loss in total knee and total hip arthroplasty","volume":"52","author":"Gortemoller","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"8","key":"r19-20240731","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.arth.2014.01.031","article-title":"Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty","volume":"29","author":"Tuttle","year":"2014","journal-title":"J Arthroplasty"},{"issue":"11","key":"r20-20240731","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1302\/0301-620X.95B11.31055","article-title":"Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures","volume":"95-B","author":"Irwin","year":"2013","journal-title":"Bone Joint J"},{"issue":"5","key":"r21-20240731","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2106\/JBJS.16.00188","article-title":"Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial","volume":"99","author":"Kayupov","year":"2017","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"r22-20240731","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.arth.2017.09.062","article-title":"Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study","volume":"33","author":"Luo","year":"2018","journal-title":"J Arthroplasty"},{"issue":"9 suppl","key":"r23-20240731","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","article-title":"The James A. Rand Young Investigator's award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?","volume":"31","author":"Fillingham","year":"2016","journal-title":"J Arthroplasty"},{"issue":"17","key":"r24-20240731","doi-asserted-by":"crossref","first-page":"e15279","DOI":"10.1097\/MD.0000000000015279","article-title":"Transfusions and cost-benefit of oral versus intravenous tranexamic acid in primary total hip arthroplasty: a meta-analysis of randomized controlled trials","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"r25-20240731","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"r26-20240731","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","author":"Owen","year":"2019","journal-title":"Res Synth Methods"},{"issue":"3","key":"r27-20240731","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/BCO.0b013e318247f1d5","article-title":"Oral tranexamic acid reduces blood loss in total knee replacement arthroplasty","volume":"23","author":"Bradshaw","year":"2012","journal-title":"Curr Orthop Pract"},{"issue":"1","key":"r28-20240731","doi-asserted-by":"crossref","first-page":"2309499016684725","DOI":"10.1177\/2309499016684725","article-title":"The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty","volume":"25","author":"Cankaya","year":"2017","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"r29-20240731","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.thromres.2018.02.007","article-title":"The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: a randomized clinical trial","volume":"164","author":"Cao","year":"2018","journal-title":"Thromb Res"},{"key":"r30-20240731","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.09.054","article-title":"Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: a prospective randomized clinical trial","volume":"171","author":"Cao","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"r31-20240731","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2106\/JBJS.20.02174","article-title":"Effect of sequential intravenous and oral tranexamic acid on hemoglobin drop after total knee arthroplasty: a randomized controlled trial","volume":"104","author":"Chang","year":"2022","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"r32-20240731","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s11999-011-1874-2","article-title":"Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial","volume":"469","author":"Charoencholvanich","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"r33-20240731","first-page":"6041827","article-title":"Effect of oral tranexamic acid on the blood transfusion rate and the incidence of deep vein thromboembolism in patients after TKA","volume":"2022","author":"Chen","year":"2022","journal-title":"Evid Based Complement Altern Med"},{"issue":"2","key":"r34-20240731","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bja.2022.11.003","article-title":"Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial","volume":"130","author":"DeFrancesco","year":"2023","journal-title":"Br J Anaesth"},{"issue":"7 suppl C","key":"r35-20240731","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1302\/0301-620X.101B7.BJJ-2018-1451.R1","article-title":"2019 Mark Coventry Award: a multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?","volume":"101-B","author":"Fillingham","year":"2019","journal-title":"Bone Joint J"},{"issue":"6","key":"r36-20240731","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.otsr.2019.06.008","article-title":"Comparison of oral vs. combined topical\/intravenous\/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: a randomised clinical trial","volume":"105","author":"King","year":"2019","journal-title":"Orthop Traumatol Surg Res"},{"issue":"1","key":"r37-20240731","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5792\/ksrr.16.074","article-title":"Blood sparing efficacy of oral tranexamic acid in primary total knee arthroplasty: a randomized controlled trial","volume":"29","author":"Lee","year":"2017","journal-title":"Knee Surg Relat Res"},{"key":"r38-20240731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.04.026","article-title":"Oral tranexamic acid is equivalent to topical tranexamic acid without drainage in primary total hip arthroplasty: a double-blind randomized clinical trial","volume":"167","author":"Luo","year":"2018","journal-title":"Thromb Res"},{"issue":"10","key":"r39-20240731","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1302\/0301-620X.103B10.BJJ-2020-2308.R1","article-title":"Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24)","volume":"103-B","author":"Magill","year":"2021","journal-title":"Bone Joint J"},{"issue":"2","key":"r40-20240731","doi-asserted-by":"crossref","first-page":"335","DOI":"10.52628\/88.2.8383","article-title":"The addition of oral Tranexamic acid to knee arthroplasty patients does not further improve blood loss: a double blinded randomized control trial","volume":"88","author":"McDonald","year":"2022","journal-title":"Acta Orthop Belg"},{"issue":"4","key":"r41-20240731","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0039-1696722","article-title":"First comparative study of the effectiveness of the use of tranexamic acid against \u03b5-aminocapr\u00f3ic acid via the oral route for the reduction of postoperative bleeding in TKA: a clinical trial","volume":"34","author":"Morales-Avalos","year":"2021","journal-title":"J Knee Surg"},{"issue":"2","key":"r42-20240731","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MBC.0000000000001005","article-title":"Tranexamic acid versus aminocapr\u00f3ic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study","volume":"32","author":"Morales-Avalos","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"r43-20240731","first-page":"397","article-title":"Tranexamic acid in joint replacement: a randomized trial comparing intravenous oral and topical routes","volume":"86","author":"Othman","year":"2020","journal-title":"Acta Orthop Belg"},{"issue":"4","key":"r44-20240731","first-page":"484","article-title":"Tranexamic acid in total knee replacement which protocol? which application form? A prospective randomised study","volume":"85","author":"\u015eahin","year":"2019","journal-title":"Acta Orthop Belg"},{"issue":"21","key":"r45-20240731","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2106\/JBJS.20.00010","article-title":"The optimal dosing regimen for tranexamic acid in revision total hip arthroplasty: a multicenter randomized clinical trial","volume":"102","author":"Sershon","year":"2020","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"r46-20240731","doi-asserted-by":"crossref","first-page":"697","DOI":"10.52628\/87.4.14","article-title":"Should tranexamic acid be used for 3 days after total knee replacement? A randomized study in 250 patients","volume":"87","author":"Shah","year":"2021","journal-title":"Acta Orthop Belg"},{"key":"r47-20240731","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijsu.2019.03.011","article-title":"The efficacy and safety of multiple doses of oral tranexamic acid on blood loss, inflammatory and fibrinolysis response following total knee arthroplasty: a randomized controlled trial","volume":"65","author":"Tang","year":"2019","journal-title":"Int J Surg"},{"issue":"12","key":"r48-20240731","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/jth.14316","article-title":"The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial","volume":"16","author":"Wang","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"1","key":"r49-20240731","doi-asserted-by":"crossref","first-page":"13579","DOI":"10.1038\/s41598-018-31791-x","article-title":"Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"r50-20240731","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1302\/0301-620X.100B8.BJJ-2017-1598.R1","article-title":"Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial","volume":"100-B","author":"Wang","year":"2018","journal-title":"Bone Joint J"},{"issue":"5","key":"r51-20240731","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2106\/JBJS.18.00128","article-title":"Finding the optimal regimen for oral tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial","volume":"101","author":"Wang","year":"2019","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"r52-20240731","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0038-1676625","article-title":"Effect of multiple doses of oral tranexamic acid on haemostasis and inflammatory reaction in total hip arthroplasty: a randomized controlled trial","volume":"119","author":"Wang","year":"2019","journal-title":"Thromb Haemost"},{"issue":"1","key":"r53-20240731","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12891-018-1996-8","article-title":"Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial","volume":"19","author":"Wang","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"key":"r54-20240731","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2018.10.006","article-title":"Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial","volume":"171","author":"Wu","year":"2018","journal-title":"Thromb Res"},{"issue":"9","key":"r55-20240731","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.arth.2017.03.059","article-title":"Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study","volume":"32","author":"Yuan","year":"2017","journal-title":"J Arthroplasty"},{"issue":"spe1","key":"r56-20240731","doi-asserted-by":"crossref","first-page":"e247197","DOI":"10.1590\/1413-785220223001e247197","article-title":"Efficacy of extended oral tranexamic acid on blood loss in primary total knee arthroplasty","volume":"30","author":"Yuenyongviwat","year":"2022","journal-title":"Acta Ortop Bras"},{"issue":"6","key":"r57-20240731","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","article-title":"The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement","volume":"99","author":"Zohar","year":"2004","journal-title":"Anesth Analg"},{"issue":"1","key":"r58-20240731","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13018-017-0660-6","article-title":"The efficacy of tranexamic acid using oral administration in total knee arthroplasty: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2017","journal-title":"J Orthop Surg Res"},{"issue":"18","key":"r59-20240731","doi-asserted-by":"crossref","first-page":"e0587","DOI":"10.1097\/MD.0000000000010587","article-title":"Efficacy and safety of oral tranexamic acid in total knee arthroplasty: a systematic review and meta-analysis","volume":"97","author":"Guo","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"r60-20240731","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42836-020-00027-7","article-title":"Comparison of oral and intravenous tranexamic acid in total hip arthroplasty: a systematic review and meta-analysis","volume":"2","author":"Qi","year":"2020","journal-title":"Arthroplasty"},{"issue":"2","key":"r61-20240731","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.injury.2021.09.063","article-title":"Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: a meta-analysis of randomized controlled trials","volume":"53","author":"Masouros","year":"2022","journal-title":"Injury"},{"issue":"3","key":"r62-20240731","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bja.2021.10.054","article-title":"Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers","volume":"128","author":"Grassin-Delyle","year":"2022","journal-title":"Br J Anaesth"}],"container-title":["JBJS Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.23.00248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:43:26Z","timestamp":1787751806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.23.00248"}},"subtitle":["A Systematic Review and Network Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.rvw.23.00248","relation":{},"ISSN":["2329-9185"],"issn-type":[{"value":"2329-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}